Anti-inflammatory dipeptide
Patent 3965260 Issued on June 22, 1976. Estimated Expiration Date: 
June 22, 1993. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
June 22, 1993. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.InventorsAssigneeApplicationNo. 593672 filed on 07/07/1975US Classes:514/192 peptide repeating units in known peptide chainExaminersPrimary: Friedman, Stanley J.AbstractThe pharmaceutical composition has a dipeptide or a pharmaceutically-acceptable salt thereof as an active ingredient. The depeptide has the general formula ##EQU1## wherein R1 and R2 are the same or different and each is either phenyl or indolyl. administration composition may be in a solid form for oral administraion in which case the active ingredient is surrounded by an enteric coating. The composition may also be in a liquid form for administration by injection in which case the active ingredient is dissolved in a physiologically compatible sterile liquid. The composition is useful in the treatment of inflammation in mammals and may be administered daily in an amount of about 40mg of the dipeptide or salt per kilogram weight of the mammal.Other References
| |
